Zacks Research Issues Positive Forecast for Integer Earnings

Integer Holdings Co. (NYSE:ITGR) – Stock analysts at Zacks Research lifted their Q2 2025 earnings per share (EPS) estimates for shares of Integer in a research report issued to clients and investors on Thursday, March 13th. Zacks Research analyst D. Dey now expects that the medical equipment provider will post earnings of $1.44 per share for the quarter, up from their previous forecast of $1.43. The consensus estimate for Integer’s current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Integer’s Q3 2025 earnings at $1.57 EPS, FY2025 earnings at $5.98 EPS, Q1 2026 earnings at $1.59 EPS, Q2 2026 earnings at $1.54 EPS, FY2026 earnings at $6.58 EPS and FY2027 earnings at $7.15 EPS.

A number of other research analysts also recently commented on ITGR. Citigroup upped their price objective on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Benchmark upped their price objective on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, February 21st. Truist Financial increased their price target on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Finally, KeyCorp raised their target price on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and a consensus target price of $149.00.

Integer Stock Performance

Shares of ITGR opened at $118.87 on Monday. The business’s 50 day moving average is $133.56 and its two-hundred day moving average is $132.61. Integer has a 52-week low of $107.11 and a 52-week high of $146.36. The firm has a market cap of $4.00 billion, a price-to-earnings ratio of 35.38, a PEG ratio of 1.72 and a beta of 1.24. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The firm had revenue of $449.50 million for the quarter, compared to analysts’ expectations of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Blue Trust Inc. lifted its position in shares of Integer by 4.4% in the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider’s stock valued at $220,000 after buying an additional 71 shares during the last quarter. Arizona State Retirement System lifted its position in shares of Integer by 0.9% in the fourth quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider’s stock valued at $1,290,000 after buying an additional 84 shares during the last quarter. HighTower Advisors LLC increased its stake in shares of Integer by 0.8% during the third quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock worth $1,579,000 after purchasing an additional 90 shares during the period. HighPoint Advisor Group LLC increased its stake in shares of Integer by 6.4% during the fourth quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 101 shares during the period. Finally, Norden Group LLC increased its stake in shares of Integer by 7.0% during the fourth quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider’s stock worth $221,000 after purchasing an additional 109 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.